Patents Assigned to LABOMED PHARMACEUTICAL COMPANY S.A.
  • Oral solutions comprising fludrocortisone acetate
    Patent number: 11771706
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: October 3, 2023
    Assignee: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios Liolios, Tsampikos Dimitrios Panagiotopoulos, Konstantinos Pachis
  • ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS
    Publication number: 20230201142
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 29, 2023
    Applicant: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios LIOLIOS, Ioannis PSARRAKIS
  • Oral solutions comprising lisdexamfetamine salts
    Patent number: 11576878
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: February 14, 2023
    Assignee: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios Liolios, Ioannis Psarrakis
  • ORAL SOLUTIONS COMPRISING FLUDROCORTISONE ACETATE
    Publication number: 20210260077
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 26, 2021
    Applicant: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios LIOLIOS, Tsampikos Dimitrios PANAGIOTOPOULOS, Konstantinos PACHIS